Synonyms: EPZ015866 | GSK3203591
Compound class:
Synthetic organic
Comment: GSK591 is a potent inhibitor of the arginine methyltransferase PRMT5 [1-2]. This in vivo tool compound is a result of collaboration between Epizyme and GlaxoSmithKline, and is being made available as part of the Structural Genomics Consortium's Epigenetics Probes Collection.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
References |
1. Duncan KW, Rioux N, Boriack-Sjodin PA, Munchhof MJ, Reiter LA, Majer CR, Jin L, Johnston LD, Chan-Penebre E, Kuplast KG et al.. (2016)
Structure and Property Guided Design in the Identification of PRMT5 Tool Compound EPZ015666. ACS Med Chem Lett, 7 (2): 162-6. [PMID:26985292] |
2. SGC.
GSK591 A chemical probe for PRMT5. Accessed on 11/12/2015. Modified on 04/08/2023. thesgc.org, https://www.thesgc.org/chemical-probes/GSK591 |